U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"The production of too many useful things results in too many useless people."

Karl Marx

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Assignee: B.R.A.H.M.S Aktiengesellschaft


Location: Hennigsdorf, DE
No. of patents: 11

NumberTitleIssue Date
7807397Diagnostic method for disorders using copeptin
The use of copeptin as diagnostic marker for the determination of the release of vasopressin, especially in connection with disorders associated with non-physiological alterations of vasopressin release from the neurohypophysis, especially for detection and early de...
10/05/2010
7659075Method for the diagnosis of sepsis with determination of soluble cytokeratin fragments
Method for early differential diagnosis and detection, for prognosis and assessment of the severity and for therapy-accompanying assessment of the course of sepsis and sepsis-like systemic infections, in which, preferably with additional determination of at least on...
02/09/2010
7517518Method for diagnosis of sepsis with determination of ca 125
The invention relates to a method for the early differential diagnosis and detection, prognosis and determination of the degree of severity of a case of sepsis and systemic infections similar to sepsis and also for the determination of the course of infection during...
04/14/2009
7413850Uses of carbamoyl phosphate synthetase for the diagnois of inflammatory diseases and sepsis
Use of carbamoyl phosphate synthetase 1 (CPS 1) and/or of fragments of the N-terminal part of CPS 1 from body fluids or body tissues as marker peptides for the diagnosis and for the prognosis and the monitoring of inflammations and infections, including sepsis, and ...
08/19/2008
7405049Method for diagnosing inflammatory diseases and infections by the determination of LASP-1 immunoreactivity
Method for early diagnosis and diagnosis, for prognosis and assessment of the severity and for therapy-accompanying monitoring of inflammatory diseases and infections, in particular sepsis-like systemic infections and Alzheimer's disease, in which the presence and/o...
07/29/2008
7358058Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease
Methods for diagnosis, early diagnosis, differential diagnosis, assessment of the severity and therapy-accompanying monitoring and prognosis of chronically inflammatory intestinal diseases (Crohn's disease, Colitis ulcerosa), in which the presence and/or the ...
04/15/2008
7235368CHP for use as marker for sepsis-type inflammatory diseases
Use of calcineurin B homologous protein (CHP) from body fluids or body tissues as a marker peptide for diagnosis, for prognosis and for monitoring the course of inflammations and infections and/or as a target for therapeutically influencing the course of inflammatio...
06/26/2007
7157081Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
Uses of aldose 1-epimerase (SEQ ID NO:3) from body fluids or body tissues in human and veterinary medicine as a marker peptide for diagnosis, for prognosis of the course and for monitoring of the course of inflammations and infections and/or as a target for therapeu...
01/02/2007
7153662Inflammation-specific peptides and the uses thereof
The invention relates to novel peptides and partial peptide sequences for the diagnosis and therapy of inflammations and sepsis, which are formed in the case of inflammations and/or infections of primates and humans, and their use or the use of antibodies formed aga...
12/26/2006
7015003Receptor binding assays and reagent kit for detecting TSH receptor autoantibodies
Improved receptor assays for the detection of thyroid stimulating hormone receptor (TSHR) autoantibodies are described which use immobilized, affinity-purified rTSHR preparations as specific binders. This format, as well as novel measures for neutralizing pathologic...
03/21/2006
6756483Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis. ...
06/29/2004
 
Sign InRegister
Username  
Password   
forgot password?